Dr. Esteban A. Henao, MD

Dr. Henao practices at New Mexico Surgery Center Multi-Specialty - Albuquerque in Albuquerque, New Mexico.

Dr. Henao's NPI, 1881653277, was assigned on March 22, 2006. Dr. Henao holds South Dakota license 12696.

Dr. Henao's primary practice is New Mexico Surgery Center Multi-Specialty - Albuquerque, at 201 Cedar St Se, Suite 7650, Albuquerque, NM 87106. The practice phone is (505) 317-9444.

Dr. Henao's primary practice is New Mexico Surgery Center Multi-Specialty - Albuquerque in Albuquerque, New Mexico. Dr. Henao is also affiliated with Presbyterian Hospital. The medical group on file is Foot & Ankle Specialists of Utah. Dmand AI also links Dr. Henao to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Henao practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Henao's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Henao's licenses on file in 3 states: South Dakota, Nebraska and New Mexico.

CMS data shows 1,473 Medicare services from Dr. Henao across 21 procedure codes in 2024, for 866 Medicare patients. Medicare paid $85,713 for them.

CMS counts 866 Medicare patients who saw Dr. Henao in 2024. The largest group is 65 to 74, with 339 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Henao's median patient age at 67, with 52% women.

In 2024, Dr. Henao wrote 111 Medicare Part D claims for 57 patients. 94% of them were for generic drugs. CMS names the drug for 96 of them, across 1 drug with 11 or more claims each, at $1,439 in total drug cost. In 2023, CMS named 132 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Henao for performance year 2024, reported as part of a group. Dr. Henao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 37 procedures of leg revascularization (restoring blood flow) by Dr. Henao, more than 92% of the clinicians it reports for that procedure.

Dmand AI links Dr. Henao to 1 clinical trial. Conditions studied include Chronic Limb-Threatening Ischemia and Peripheral Arterial Disease. Open Payments lists research payments to Dr. Henao that name 1 trial.

CMS Open Payments shows 1,395 general payments to Dr. Henao from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 33% of the total. Boston Scientific Corporation paid the most, $202,788. It also lists 2 research payments totaling $1,360 from 2016 to 2020, naming 1 clinical trial.